Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial.
- DOI
- 10.1002/alz.70347
- Published
- 2025 Jul
- Container
- Alzheimer's & dementia : the journal of the Alzheimer's Association
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/alz.70347,
title = {Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial.},
author = {McCullough A and Chen CD and Gordon BA and Joseph-Mathurin N and Jack CR Jr and Koeppe R and Hornbeck R and Koudelis D and McKay NS and Hobbs DA and Flores S and Keefe SJ and Aggarwal NT and Allegri RF and Berman SB and Bird T and Black SE and Brooks WS and Chhatwal JP and Day GS and Farlow MR and Fox NC and Gauthier S and Honig LS and Hsiung GY and Jucker M and Levin J and Masellis M and Masters C and Mendez PC and Ringman JM and Snider BJ and Salloway S and Schofield PR and Shimada H and Suzuki K and van Dyck CH and Klein G and Clifford DB and Cruchaga C and Hassenstab J and Li Y and McDade E and Mills S and Morris JC and Perrin RJ and Supnet-Bell C and Wang G and Xiong C and Bateman RJ and Benzinger TLS and DIAN‐TU Study Team},
year = {2025},
journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
doi = {10.1002/alz.70347},
url = {https://doi.org/10.1002/alz.70347}
}RIS
TY - JOUR TI - Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial. AU - McCullough A AU - Chen CD AU - Gordon BA AU - Joseph-Mathurin N AU - Jack CR Jr AU - Koeppe R AU - Hornbeck R AU - Koudelis D AU - McKay NS AU - Hobbs DA AU - Flores S AU - Keefe SJ AU - Aggarwal NT AU - Allegri RF AU - Berman SB AU - Bird T AU - Black SE AU - Brooks WS AU - Chhatwal JP AU - Day GS AU - Farlow MR AU - Fox NC AU - Gauthier S AU - Honig LS AU - Hsiung GY AU - Jucker M AU - Levin J AU - Masellis M AU - Masters C AU - Mendez PC AU - Ringman JM AU - Snider BJ AU - Salloway S AU - Schofield PR AU - Shimada H AU - Suzuki K AU - van Dyck CH AU - Klein G AU - Clifford DB AU - Cruchaga C AU - Hassenstab J AU - Li Y AU - McDade E AU - Mills S AU - Morris JC AU - Perrin RJ AU - Supnet-Bell C AU - Wang G AU - Xiong C AU - Bateman RJ AU - Benzinger TLS AU - DIAN‐TU Study Team PY - 2025 JO - Alzheimer's & dementia : the journal of the Alzheimer's Association DO - 10.1002/alz.70347 UR - https://doi.org/10.1002/alz.70347 ER -
APA
A, M., CD, C., BA, G., N, J., Jr, J. C., R, K., R, H., D, K., NS, M., DA, H., S, F., SJ, K., NT, A., RF, A., SB, B., T, B., SE, B., WS, B., JP, C., GS, D., MR, F., NC, F., S, G., LS, H., GY, H., M, J., J, L., M, M., C, M., PC, M., JM, R., BJ, S., S, S., PR, S., H, S., K, S., CH, V. D., G, K., DB, C., C, C., J, H., Y, L., E, M., S, M., JC, M., RJ, P., C, S., G, W., C, X., RJ, B., TLS, B., & Team, D. S. (2025). Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial.. Alzheimer's & dementia : the journal of the Alzheimer's Association. https://doi.org/10.1002/alz.70347
Source records
- pubmed · retrieved 2026-09-24T22:48:20.153Z
- europe-pmc · retrieved 2026-09-24T22:48:20.152Z